Biotechnology Market Research Reports

• Specimen Validity Testing Market by Type (POC Testing, Laboratory), Product (Assay Kits, Reagent, Controls, Disposables), End User (Pain Management, Workplace, Drug Screening, Drug Rehabilitation Centers) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Creatinine Assay Kits Market by Sample (Urine, Blood, Serum, Sweat, Saliva, CSF, Tissue Homogenate), Type (ELISA, Jaffe’s Kinetic Test, Creatinine-PAP), Region (Europe, North America, Asia and RoW) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Regenerative Medicine Market by Applications (Musculoskeletal, Wounds & Dermal, Oncology), Type (Cell Therapy (Allogeneic & Autologous Products), Cell-Based Immunotherapy Tissue Engineering, Gene Therapy), Region – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• 3D Bioprinting Market by Technology (Inkjet, Microextrusion, Laser, Magnetic), Material (Extracellular Matrices, Cells, Hydrogels, Biomaterials), Application (Research (Regenerative Medicine) & Clinical (Cartilage, Bone, Skin)) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Reporter Gene Assay Market by Application (Protein Interaction, Gene Regulation, Cell Signalling Pathways), Reagents & Assay kits (Green Fluorescent Protein, Luciferase, â-glucuronidase, â-galactosidase), End Users, Region – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Hydrophobic Interaction Chromatography Market by Sample (Vaccines, Monoclonal Antibodies), Product & Services (Resin, Buffer, Columns (Prepacked, Empty)), End User (CROs & CMOs, Pharmaceutical Companies, Research Institutes) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Transfer Membrane Market by End user (Pharmaceutical Companies, Academia, Diagnolab), Type (Nylon, PVDF, Nitrocellulose), Transfer Method (Dry, Tank, Semi-dry), Application (Protein Sequencing, Western, Northern, Southern Blot) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Cell Analysis Market by End User (Research, Pharma, Biotechnology Companies), Product (Microscope, Spectrophotometers, Flow cytometry), Process (Cell Proliferation, Cell Viability, Signal Transduction) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Mice Model Market by Application (Oncology, Diabetes), Technology (Microinjection), Type (Hybrid, Inbred, Knockout), Service (Genetic testing, Breeding, Quarantine) & Care Products (Bedding, Feed) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Biochips Market Size & Share by End user (Diagnostics Centers, Academics Institutes), by Type (DNA Chip, Lab-on-a-chip, Protein Chips), Fabrication Technology (Microfluidics, Microarrays) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Dairy Herd Management Market by Application (Breeding, Feeding), Product (Software (Cloud-based, On-premise), Automated Systems (Sensors, Milking Parlours, Meters, Reproductive & Health, Cattle Management)), End user (Large Farms) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Next-generation Sequencing Market by Product (SEQUEL, NOVASEQ, NEXTSEQ, NANOPORE), Consumables, Bioinformatics, Technology (ION, SMRT), Services (DENOVO, EXOME, RNA), Application, End User, Region – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• qPCR Reagents Market by Application (Research, Diagnostic, Forensic), Detection (Probe-based, Dye-based), Packaging (Master Mixes, qPCR Core Kits), End User (Academia, Research Labs, Hospitals, Diagnostic Centers, CRO) – 2023 to 2023

  $3,850.00 – $5,850.00
  Published on:
  Select options

• NGS-Based RNA-Sequencing Market by Application (Epigenetics, small RNA, De Novo), Technology (SBS, SMRT, Nanopore), Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), End-User, Region – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Blood Screening Market by Product (Instrument, Reagent & Kits, Software), Technology (Nucleic Acid Amplification, ELISA, Rapid Test, Western Blot), End User (Blood Bank, Hospital) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Transplant Diagnostics Market by Type (Heart, Kidney, Liver, Bone Marrow), Application (Pathogen Detection, HLA, Blood Profile), Technology (Sanger Sequencing, PCR, NGS), Product (Software, Instrument, Reagent), End User (Hospital) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• U.S. Hemodialysis Field Market by Product Type, by Modality, End-user, Region – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Cell Surface Markers Market by Application (Research, Clinical), Product (PCR Array, Antibody), Source (Rat, Mice), Cell Type, and End User – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Patient Derived Xenograft/PDX Models Market by Application (Biomarker Analysis and Pre-Clinical Drug Development), Type (Mouse & Rat), Tumor Type (Gynecological, Gastrointestinal, Respiratory), End User (Pharma & Biotech, CRO) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options

• Microarray Analysis Market by Application (Research), Product & Service (Software, Consumables, Instrument, Services), Type (DNA, Protein Microarray), End User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories) – 2023 to 2028

  $3,850.00 – $5,850.00
  Published on:
  Select options
Page 3 of 10‹ Previous1234567Next ›Last »

The Biotechnology Industry is witnessing an increase in collaborative partnerships with a view to developing newer techniques. During its “green wave” period the industry produced a number of agricultural applications. During its “red wave”, there were a number of developments in the medical space to target disease prevention and management. In its “white wave”, industrial applications were at the forefront. A further rise in demand for therapeutics and diagnostic solutions on principles of ‘red wave’, DNA sequencing, and recombinant technology is expected to propel huge growth. Prevention, management and cure of chronic diseases such as hepatitis B, cancer, HIV and childhood disorders is expected to further fuel growth. Optimized development of DNA technology is expected to serve this sector as a high impact rendering growth driver. It is expected to encourage researchers and manufacturers to increase R&D initiatives targeted at understanding genetic variations and developing therapeutic solutions for chronic diseases with large global prevalence such as cardiovascular diseases, diabetes, and cancer. Personalised medicine, biosimilars, bioinformatics, management of genomic data through studies on plants, animals and human genomes is also expected to drive segment growth during the forecast period.

Our reports provide application insights, technology insights, regional insights and competitive insights on biomaterials, genomics, proteomics, bioinformatics, biomarkers, biosimilars, drug delivery and discovery, stem cell, food and agriculture technology and tissue regeneration technology. To know more about our offerings in the Biotechnology market analysis, contact us.

The Biotechnology Industry is witnessing an increase in collaborative partnerships with the primary view of developing newer and pathbreaking technology. The market is set to expand at 9.9 percent CAGR to hit USD 775 billion by 2024 mainly on account of increase in the incidence of chronic diseases such as diabetes and cancer, development of technology innovation and favorable government conditions. The ratio of chronic disease all around the globe is continuously increasing, which is analyzed to propel growth in the industry overall. According to recent data, the estimated number of people affected by the chronic disease will rise to 629 million by 2045. Approximately half of America’s population suffers from at least one chronic disease and this number is growing continuously. These statistics are expected to pave the way for opportunities in the biotechnology market.

The industry has experienced what is known as a ‘wave’ phenomenon. During its ‘green wave’ period the industry produced a number of agricultural applications. During its ‘red wave’, there were a number of developments in the medical space to target disease prevention and management. In its ‘white wave’, industrial applications were at the forefront. A further rise in demand for therapeutic and diagnostic solutions on principles of ‘red wave’, DNA sequencing, and recombinant technology is expected to propel huge growth. Prevention, management and cure of chronic diseases such as hepatitis B, cancer, HIV and childhood disorders is also expected to boost fuel growth. Optimized development of DNA technology is expected to serve this sector as a high impact-rendering growth driver. It is expected to encourage researchers and manufacturers to increase research and development initiatives targeted at understanding genetic variations and developing therapeutic solutions for chronic diseases with large global prevalence such as cardiovascular diseases, diabetes, and cancer. Personalized medicine, biosimilars, bioinformatics, management of genomic data through studies on plants, animals and human genomes is also expected to drive segment growth during the forecast period.

Global Market Studies’ Biotechnology Market Research reports analysis provide application insights, technology insights, regional insights and competitive insights vis-a-vis the subsectors of biomaterials, biomanufacturing, genomics, proteomics, bioinformatics, biomarkers, biosimilars, drug delivery and discovery, stem cell, food and agriculture technology and tissue regeneration technology, among others. Key competitor analysis includes that of Agilent Technologies, Amgen, Abbott Laboratories, Bio-Rad Laboratories, BioGen Medical Instruments, Danaher, Merck, F. Hoffmann-La Roche, Illumina, PerkinElmer, Thermo Fisher Scientific and Qiagen.

Contact us at Global Market Studies to know more about our offerings in the Biotechnology sector.